TURBt With Adjuvant Cryoablation to Treat Bladder Cancer

• Status: Unknown status
• Trial end date: 2018-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety and efficacy of applying cryoablation as an adjuvant therapy with TUR to treat bladder tumor.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Huashan Hospital
• Collaborators: Shanghai 5th People's Hospital; Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University; Shanghai Zhongshan Hospital; Zhejiang Provincial People's Hospital
• Treatments: Epirubicin

Criteria

Inclusion Criteria:

• Clinically diagnosed bladder tumor, stage T1 or T2

• Number of lesions ≤ 3

• Tumor size ≤ 3cm

Exclusion Criteria:

• With other malignant diseases

• T3 or above

• Enlarged pelvic lymph node or distant metastasis

• Poor overall condition